Search results
FDA advisors reject MDMA therapy for PTSD, amid concerns over research
WUSF 89.7· 39 minutes agoIt represents a major setback for proponents of the drug and Lykos Therapeutics, which sponsored...
FDA panel rejects MDMA therapy for treating patients with PTSD
WSB Radio· 30 minutes agoAn independent advisory panel of the Food and Drug Administration on Tuesday rejected the use of ...
FDA advisers vote against first MDMA therapy to treat PTSD
CNN via Yahoo News· 1 hour agoA federal advisory committee on Tuesday voted overwhelmingly against of the use of MDMA, commonly...
FDA advisers vote against recommending approval of MDMA as treatment for PTSD
ABC News· 2 hours agoFood and Drug Administration voted against recommending approval of psychedelic treatment -- along...
F.D.A. Panel Rejects MDMA-Aided Therapy for PTSD
New York Times· 2 hours agoAn independent advisory panel of the Food and Drug Administration rejected the use of MDMA-assisted therapy for post-traumatic stress disorder on Tuesday...
Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication
Pittsburgh Tribune-Review· 8 hours agoFederal health advisers are weighing the first-of-a-kind approval of MDMA, the mind-altering club...
MDMA Treatment for PTSD Gets Voted Against by FDA Advisers
TMZ· 2 hours agoA pharmaceutical version of MDMA, also known as midomafetamine, could become a new treatment for ...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 27 minutes agoLykos Therapeutics Provides Update on FDA Advisory Committee Meeting for Investigational MDMA-Assisted Therapy for PTSD PR Newswire SAN ...
FDA panel votes against MDMA therapy for PTSD, citing muddy data and safety concerns
BioPharma Dive via Yahoo Finance· 6 hours agoA group of independent experts wasn't convinced by clinical trial data from company Lykos...
Flawed, scandalous trials tank FDA expert support for MDMA therapy
Ars Technica· 1 hour agothe advisors voted 10 "no" to 1 "yes" against MDMA. The votes come after a full-day meeting in which...